IL6 and COVID-19: For this COVID-19 patient with kidney transplant, favipiravir together with decreased immunosuppression and IL-6 inhibitor antibody provides favorable outcomes. Decision on timing for IL-6 inhibitor initiation can be guided by IL-6 level monitoring